Delivery Order SPE2DB24D2205-SPE2DB25FECQN
- Not listed
- The Defense Logistics Agency awarded a $3,013.61 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mucinex D ER 600-60 mg tablets (18-count units) on July 24, 2025, with completion targeted for July 25, 2025. This non-set-aside delivery order represents a routine pharmaceutical supply transaction supporting federal medical procurement needs. The award was issued to AmerisourceBergen's Corporate Office division, with performance to occur at the company's headquarters in...
- The Defense Logistics Agency awarded a delivery order valued at $1,410.00 to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count packages). This is a firm fixed-price delivery order with an ultimate completion date of August 19, 2025, and represents a non-competitive set-aside. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count units) with a ceiling value of $1,467.93. This non-set-aside, firm fixed-price delivery order is scheduled for completion by June 3, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count units) with a ceiling value of $3,206.04. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, reflecting the company's competitive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count packages) with a ceiling value of $2,526.92. This non-competitive delivery order represents a firm fixed-price transaction with an ultimate completion date of August 21, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award leverages AmerisourceBergen's existing relationship with the DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,102.78 to AmerisourceBergen Drug Corp for Mucinex D ER 600-60 mg tablets (18-count units) on September 17, 2025, with an ultimate completion date of September 18, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania, which serves as the...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Mucinex D ER 600-60 mg tablets in quantities of 18 units. This firm fixed-price delivery order, valued at $10,118.97, is scheduled for completion by September 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Mucinex D ER 1,200-120 mg tablets (24-count packages) valued at $3,066.65. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract under open competition. The order is scheduled for ultimate completion on August 21, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,680.12 to AmerisourceBergen Drug Corp for Mucinex D ER 600-60 mg tablets (18-count packaging) on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-set-aside, competitively awarded contract utilized firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger federal contract portfolio. The product will be delivered to the company's headquarters location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count) with a ceiling value of $2,218.14. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for ultimate completion by July 28, 2025, and will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. This delivery order is...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FECQNDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count packages) with a ceiling value of $2,553.51. This is a firm fixed-price delivery order with no set-aside designation, performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of May 21, 2025. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through competitively awarded contracts with the Defense Logistics Agency's Medical Supply Chain. The company's extensive portfolio demonstrates capability across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. This particular delivery order reflects the type of routine pharmaceutical procurement that AmerisourceBergen executes regularly through its prime indefinite delivery vehicle, supporting military medical readiness and healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 5/20/25 |